| 000 | 01804 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514014601.0 | ||
| 264 | 0 | _c20011207 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.50.11.2619 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFabris, B | |
| 245 | 0 | 0 |
_aModulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor. _h[electronic resource] |
| 260 |
_bDiabetes _cNov 2001 |
||
| 300 |
_a2619-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xpathology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aIsoquinolines _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _xenzymology |
| 650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xblood |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aQuinapril |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSerum Albumin _xmetabolism |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 700 | 1 | _aCandido, R | |
| 700 | 1 | _aCarraro, M | |
| 700 | 1 | _aFior, F | |
| 700 | 1 | _aArtero, M | |
| 700 | 1 | _aZennaro, C | |
| 700 | 1 | _aCattin, M R | |
| 700 | 1 | _aFiorotto, A | |
| 700 | 1 | _aBortoletto, M | |
| 700 | 1 | _aMillevoi, C | |
| 700 | 1 | _aBardelli, M | |
| 700 | 1 | _aFaccini, L | |
| 700 | 1 | _aCarretta, R | |
| 773 | 0 |
_tDiabetes _gvol. 50 _gno. 11 _gp. 2619-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.50.11.2619 _zAvailable from publisher's website |
| 999 |
_c11596450 _d11596450 |
||